Article Text

AB0080 Modualtion of immunoglobulin G2B binding in combination of methotrexate and aconite in a collagen-induced arthritis setting
  1. D-S Oh,
  2. G Park,
  3. SH Lee
  1. The K-herb Research Centre, Korea Institute of Oriental Medicine, Daejeon, Korea, Republic Of


Background Our previous study showed synergistic responses in TNF-alpha (TNF-α) and interleukin-6 with the combination of methotrexate (MTX) and aconite. Modulation of those cytokines has not been applied to rheumatoid arthritis (RA)-mimicked in vivo models.

Objectives To translate in vitro effects of MTX, aconite, and MTX/aconite combination towards anti-arthritic responses in vivo, we investigated arthritis index (AI), histopathologic changes, and levels of TNF-α, immunoglobulin G (IgG) 2a and 2b in a collagen-induced arthritis (CIA) setting.

Methods CIA was induced in five male DBA/OlaHsd mouse per group by intradermal injection of bovine collagen type II and Complete Freund's Adjuvant. In Day21, a bovine collagen type II and Incomplete Freund's Adjuvant were given for booster infection. The mice of arthritis onset were treated daily throughout Day49 with per oral administration of pre-investigated ratios of three to one; MTX (3 mg/kg), aconite (Aconibal®, 1 mg/kg), and MTX/aconite (3 and 1 mg/kg) combination. The AIs were evaluated every week. Histological changes, levels of TNF-α as well as IgG2a and IgG2b in blood using ELISA kit were evaluated at finals. Repeat measure and one-way ANOVA were analysed using SPSS (ver. 18.0 KO for Windows; SPSS Inc., Chicago, IL, USA) to evaluate inter-period and inter-group differences with Tukey's post-hoc tests.

Results The CIA phenotypes adequately presented through three groups' AI reductions (CIA vs. MTX, aconite, or MTX/aconite; p<0.001, for three). There were differences of AI scores in aconite group from MTX one in week 4, 5, and 6 (MTX vs. aconite; p=0.038, p=0.001, p=0.042, respectively). Synergistic responses of AI were not shown any of three groups. The recoveries of synovial tissues were observed in MTX and MTX/aconite groups. The levels of TNF-α were not changed (aconite vs. MTX/aconite; p=0.200 and MTX vs. MTX/aconite; p=0.700). MTX group showed IgG2a reduction (CIA vs. MTX; p<0.001). Interestingly, MTX/aconite combination and aconite group slightly downregulated IgG2b levels as 80.8±5.6% and 90.5±7.4%, respectively (CIA vs. MTX/aconite; p=0.001 and CIA vs. aconite; p=0.010).

Conclusions Synergistic in vitro effects of MTX and aconite combination brought the partial in vivo phenotypic responses: Aconite showed more AI changes than MTX did in 4, 5, and 6 weeks. However, we found the presence of partial FcγRIIB affinity of binding modulation that MTX/aconite could enhance preventing monocyte/macrophage activation via immune complex in RA pathogenesis, as was other benefits of the combination except direct synergies.


  1. Oh DS, Park G, Choi S. Characterising multiple molecule-modulating response of TNF-alpha and interleukin-6 by combination of methotrexate and aconite in interferon gamma-induced toxicity setting. Ann Rheum Dis 2016;75:Suppl2 909–910.

  2. Wijngaarden S, van Roon JA, van de Winkel JG, Bijlsma JW, Lafeber FP. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment. Rheumatology (Oxford) 2005;44:729–734.

  3. Stewart R, Hammond SA, Oberst M, Wilkinson RW. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment. J Immunother Cancer 2014;2:29.


Acknowledgements This study was supported by KIOM (Grant # K17252). The commercial product was donated by the virtue of HanPoong Pharmaceutical Company.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.